Study of prognostic factors affecting outcome of urosepsis in a tertiary care hospital in Mumbai
DOI:
https://doi.org/10.18203/2349-2902.isj20160211Keywords:
Kidney, Urospesis, Prognosis, Clinical outcomeAbstract
Background: Urosepsis implies clinically evident severe infection of the urinary tract and/or the male genital tract (e.g. prostate) with features consistent with systemic inflammatory response syndrome. This research was aimed at studying various prognostic factors of urosepsis and its outcome.
Methods: We prospectively observed patients admitted at Lokmanya Tilak Municipal General Hospital (LTMGH), Mumbai with a confirmed diagnosis of urosepsis from January 1, 2014 to December 31, 2014. After collecting socio-demographic data, patients were worked up with blood culture, urine routine and culture and other relevant clinical data. Data were analyzed in SPSS statistical software (SPSS v20 Inc, Chicago, USA).
Results: 100 patients were included in the final of which 51 were males and 43 were aged 40-60 years. 49 patients had diabetes mellitus, 24 had a history of urethral procedures. 39% of the patients had E.coli and 40% of the patients reported no organisms. Additionally, 50% of the patients reported shock as a complication. Presence of pus cells in urine showed statistically significant association with mortality, duration of hospital stay and residual renal impairment.
Conclusions: Urosepsis is much prevalent but rarely studied disease. Various clinical and microbiological parameters of the patient are of prognostic value and can predict the clinical outcome.
Metrics
References
Kalra OP, Raizada A. Management issues in urinary tract infections. J Gen Med. 2006;18:16-22.
Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-50.
Johansen TE, Cek M, Naber K, Stratchounski L, Svendsen M, Tenke P. Prevalence of hospital acquired urinary tract infections in urology departments. Eur Urol. 2007;51:1100-12.
Gastmeier P, Kampf G, Wischnewski N, Hauer T, Schulgen G, Schumacher M. Prevalence of nosocomial imfections in representative German hospitals. J Hosp Infect. 1998;38:37-49.
Rosser CJ, Bare RL, Meredith JW. Urinary tract infections in the critically ill patient with a urinary catheter. Am J Surg. 1999;177:287-90.
India stats: Million plus cities in India as per Census. Press Information Bureau, Mumbai (Press release). Press Information Bureau, Government of India. 2011.
Wagenlehner FM, Weidner W, Naber KG. Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis. Clin Pharmacokinet. 2007;46:291-305.
Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Pharmacoepidemiol Drug Saf. 2010;19(12):1287-92.
Groop L, Laasonen L, Edgren J. Renal papillary necrosis in patients with IDDM. Diabetes Care. 1989;12:198-202.
Tenke P, Kovacs B, Bjerklund Johansen TE. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents. 2008;31S:S68-78.
Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Pharmacoepidemiol Drug Saf. 2010;19(12):1287-92.
Bonadio M, Meini M, Spitaleri P, Gigli C. Current microbiological and clinical aspects of urinary tract infections. Eur Urol. 2001;40(4):439-44.
O'Keeffe NK, Mortimer AJ, Sambrook PA, Rao PN. Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones. British Journal of Urology. 1993;72(3):277-83.
Nebrada-Mayoral T, Munoz-Bellido JL, Garcia-Rodriguez JA. Incidence and characteristics of urinary tract infections caused by Corynebacterium urealyticum (Corynebacterium group D2). Eur J Microbiol Infect Dis. 1994;13:600-4.
Downloads
Published
How to Cite
Issue
Section
